Women, aspirin & cancer
This article was originally published in The Tan Sheet
"Extended aspirin use may be associated with significantly increased cancer risk among women," Eva Schernhammer, MD, Harvard University Medical School, et al., reported at a meeting of the American Association for Cancer Research in Phoenix Oct. 26-30. Among 88,378 participants in the Nurses' Health Study, researchers identified 161 cases of pancreatic cancer in previously cancer-free individuals. The risk increased 58% for women who took aspirin twice a week or more for more than 20 years. "These findings, if confirmed, add another variable to the complex risk-benefit profile of aspirin," Schernhammer cautioned...
You may also be interested in...
Results of a newly published study indicating that women who use aspirin two or more times per week are at an increased risk of pancreatic cancer are not "conclusive," Bayer Consumer Care maintains
Public Company Edition: Mergers with special purpose acquisition corporations may be heating up, but in addition to the Surrozen and Tango SPAC deals Recursion and Biomea launched initial public offerings. Also, Organon sells $5.6bn worth of notes to fund spinout from Merck & Co.
Efforts to improve trial diversity predate COVID-19, but the pandemic’s disproportionate effects on minority communities have brought the issue to the forefront.